Institute of Pharmacology and Toxicology, University of Zürich, Zürich, Switzerland.
Neuroscience Center Zurich, University and ETH Zurich, Zurich, Switzerland.
J Neurochem. 2024 Mar;168(3):163-184. doi: 10.1111/jnc.16045. Epub 2024 Jan 30.
This review explores the evolving landscape of G-protein-coupled receptor (GPCR)-based genetically encoded fluorescent indicators (GEFIs), with a focus on their development, structural components, engineering strategies, and applications. We highlight the unique features of this indicator class, emphasizing the importance of both the sensing domain (GPCR structure and activation mechanism) and the reporting domain (circularly permuted fluorescent protein (cpFP) structure and fluorescence modulation). Further, we discuss indicator engineering approaches, including the selection of suitable cpFPs and expression systems. Additionally, we showcase the diversity and flexibility of their application by presenting a summary of studies where such indicators were used. Along with all the advantages, we also focus on the current limitations as well as common misconceptions that arise when using these indicators. Finally, we discuss future directions in indicator engineering, including strategies for screening with increased throughput, optimization of the ligand-binding properties, structural insights, and spectral diversity.
本综述探讨了基于 G 蛋白偶联受体 (GPCR) 的遗传编码荧光指示剂 (GEFI) 的不断发展的领域,重点介绍了它们的开发、结构组成、工程策略和应用。我们强调了该指示剂类别独特的特征,强调了传感域(GPCR 结构和激活机制)和报告域(环状排列荧光蛋白(cpFP)结构和荧光调制)的重要性。此外,我们还讨论了指示剂工程的方法,包括合适的 cpFP 的选择和表达系统。此外,我们通过总结使用这些指示剂的研究,展示了它们应用的多样性和灵活性。除了所有的优势外,我们还关注使用这些指示剂时出现的当前限制和常见误解。最后,我们讨论了指示剂工程的未来方向,包括提高高通量筛选、优化配体结合特性、结构见解和光谱多样性的策略。